Skip to main content
. 2022 Jul 5;10(7):1597. doi: 10.3390/biomedicines10071597

Figure 7.

Figure 7

The structures of anti-TfR (transferrin receptor) antibody-drug conjugate (ADC), containing cancer drugs via pH-sensitive cleavable linkers.